HOME >> BIOLOGY >> NEWS
American Chemical Society's Weekly PressPac -- July 11, 2007

ham/asap/pdf/ac0706271.pdf
DOWNLOAD HTML http://pubs.acs.org/cgi-bin/sample.cgi/ancham/asap/html/ac0706271.html

CONTACT:
Dana M. Spence, Ph.D.
Wayne State University
Detroit, Michigan 48202
Phone: 313-577-8660
Fax: 313-577-2942
Email: dspence@chem.wayne.edu


ARTICLE #2 FOR IMMEDIATE RELEASE

Healthful compounds in tomatoes increase over time in organic fields
Journal of Agricultural and Food Chemistry

Levels of flavonoids increase over time in crops grown in organically farmed fields, according to a rare long-term study scheduled for publication in the July 18 issue of ACS Journal of Agricultural and Food Chemistry, a bi-weekly publication. Other research has suggested that consumption of flavonoids may protect against cancer, heart disease, and other age-related diseases.

In the new study, Alyson E. Mitchell and colleagues compared levels of key flavonoids in tomatoes harvested over a 10-year period from two matched fields one farmed organically and the other with conventional methods that included commercial fertilizers. The research focused on tomatoes because per capita consumption in the United States is so high, second only to potatoes. Researchers analyzed organic and conventional tomatoes that had been dried and archived under identical conditions from 1994 to 2004.

The levels of flavonoids increased over time in samples from organic treatments, whereas the levels of flavonoids did not vary significantly in conventional treatments, their report stated. Increases corresponded with the accumulation of soil organic matter in organic plots and with reduced fertilization rates. Well-quantified changes in tomato nutrients over years in organic farming systems have not been reported previously.


'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
16-Jul-2007


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. American Chemical Society meets Aug. 19-23 in Boston
4. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
5. American buffalo slaughter fueled by international trade
6. American Chemical Societys Weekly PressPac -- July 25, 2007
7. American Chemical Societys Weekly PressPac -- July 18, 2007
8. Tips from the Journals of the American Society for Microbiology
9. Wiley extends publishing partnership with the American Institute of Chemical Engineers
10. Highlights from the July 2007 Journal of the American Dietetic Association
11. Scientific American launches innovative new version of magazine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Chemical Society Weekly PressPac July

(Date:5/22/2013)... YORK, May 22, 2013. Plastic additives known as ... about everywhere: They turn up in flooring, plastic ... to the Centers for Disease Control and Preventionthe ... phthalates have come under increasing scrutiny. A growing ... (which can leech from packaging and mix with ...
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
(Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... May 21, 2013 According to ... ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the ... and is expected to grow at a CAGR of ... value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: